Regenerative medicine has become a key focus worldwide and the number of stem cell-based clinical trials are rapidly increasing every year. Yet, large-scale and GMP-compliant stem cell manufacturing ...
Regenerative medicine has become a key focus worldwide and the number of stem cell, especially pluripotent stem cell (PSC)-based clinical trials are rapidly increasing every year. Yet, large-scale and ...
Syena secures exclusive license to Miltenyi Biotec’s PRAME TCR Syena, co-founded by Replay and MD Anderson in 2023, will develop an off-the-shelf PRAME TCR-NK cell therapy, with IND anticipated Q1 ...